Patients with bronchiectasis in China have a high disease burden and a low rate of use of evidence-based treatments.

Insmed Incorporated INSM announced that the FDA has accepted its new drug application (“NDA”) seeking approval of its reversible inhibitor of dipeptidyl peptidase 1 (DPP1), brensocatib, for treating ...

More than that, my latest PET CT showed damage to the airways in my lungs from all those months of coughing and illness. The official name for this latest ailment is bronchiectasis, a condition in ...

The Bridgewater, N.J., biopharmaceutical company said brensocatib has the potential to become the first and only approved treatment for non-cystic fibrosis bronchiectasis, which causes the lungs' ...

Almost 200 species of NTM are known to us, some of which can lead to diseases such as bronchiectasis ... Results of prior lung function testing (spirometry, lung volumes, DLCO, ct.). Despite our best ...

Antibiotics are the main treatment for this medical condition. “Bronchiectasis can only be diagnosed by lung scans, but GPs can suspect it if somebody’s getting lots of infections or lots of ...